Hosted by Dailymotion. For legal issues report at the Copyright Center, report us on DMC, or use the Instant Removal tool.
Biogen’s Q2 Earnings
Description
Fueled by their Alzheimer's drug, Biogen’s ($BIIB@US) earnings report beat expectations as they reported $2.78 billion in revenue, beating the $2.61 billion projected by analysts. Their controversial Alzheimer's drug saw $2 million in revenue after only being approved a few weeks ago. Shares of Biogen were down 0.59% today at press time.
Keywords & Tags
More from User
00:55
Apple Hikes Incoming
Benzinga
00:58
Trump Settles Niece Lawsuit
Benzinga
00:58
House Eyes Airline Rules
Benzinga
00:57
Intel-Apple Deal
Benzinga
00:50
Senate Targets Buybacks
Benzinga
00:58
CarMax Stock Sinks
Benzinga
Related Videos
19:57
Wipro CFO Jatin Dalal On Q2 Earnings; Projections For Margin & Attrition
NDTV Profit
18:49
#BQExclusive | TCS CEO K. Krithivasan On Q2 Earnings & FY24 Growth Projections
NDTV Profit
02:13
Walmart Q2 Earnings Highlights: Company Reported Better-Than-Expected Q2 Earnings And Raised FY24 Outlook, What Investors Need To Know
Benzinga
11:46
HDFC CEO Keki Mistry On Q2 Report Card & FY23 Projections | Q2 Review | BQ Prime
NDTV Profit
12:31
Q2 Review: Dixon Tech CFO On Q2 Earnings & Outlook For Coming Quarters
NDTV Profit
00:53
FedEx Q2 Earnings Highlights: Stock Takes A Hit After The Company Posts Weak Q2 Financial Results
Benzinga